We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M Turnover 20%
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+34.2%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$707M
AUM Growth
+$170M
Cap. Flow
+$38.8M
Cap. Flow %
5.49%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
1
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
ONCR
Oncorus, Inc.
ONCR
+$66M

Top Sells

Rank Stock Value
1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$27.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ITOS icon
1
DELISTED
iTeos Therapeutics
ITOS
$125M 17.74%
3,706,663
– –
2020 Q3
1 quarter
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$125M 17.73%
4,050,865
– –
2019 Q1
7 quarters
DYN icon
3
Dyne Therapeutics
DYN
$2.81B
$104M 14.71%
4,951,303
– –
2020 Q3
1 quarter
RPTX icon
4
DELISTED
Repare Therapeutics
RPTX
$103M 14.58%
3,003,772
– –
2020 Q2
2 quarters
ONCR
5
DELISTED
Oncorus, Inc.
ONCR
$92.1M 13.04%
+2,849,464
New +$66M
2020 Q4
0 quarters
HARP
6
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$75.2M 10.63%
452,443
– –
2019 Q1
7 quarters
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$5.97B
$56.8M 8.03%
1,909,258
– –
2017 Q4
12 quarters
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
$25M 3.53%
5,736,296
– –
2015 Q3
21 quarters
SNDX icon
9
Syndax Pharmaceuticals
SNDX
$1.21B
– –
-1,843,388
Closed -$27.2M –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, MPM Asset Management held 9 positions worth $707M, up 32% from $536M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $38.8M of net new capital in Q4 2020, opening 1 new position. Its largest new stake was Oncorus, Inc.: 2,849,464 shares worth $92.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Syndax Pharmaceuticals, an estimated $27.2M sold.

  • MPM Asset Management's largest Q4 2020 buy was Oncorus, Inc.: 2,849,464 shares worth $92.1M.
  • MPM Asset Management fully exited Syndax Pharmaceuticals in Q4 2020, selling an estimated $27.2M.
  • MPM Asset Management's ten largest holdings make up 100% of its $707M portfolio in Q4 2020.
  • MPM Asset Management opened 1 new position and closed 1 in Q4 2020.
  • MPM Asset Management's portfolio value rose 32% quarter-over-quarter to $707M.

Based on MPM Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.